Infection control of COVID-19 in pediatric tertiary care hospitals: challenges and implications for future pandemics.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
26 04 2022
Historique:
received: 17 08 2021
accepted: 14 04 2022
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

More than 2 years into the COVID-19 pandemic, SARS-CoV-2 still impacts children's health and the management of pediatric hospitals. However, it is unclear which hygiene and infection control measures are effective and useful for pediatric hospitals. Here, we report infection control measures implemented at a tertiary care children's hospital. We evaluated frequency of SARS-CoV-2 detection in admitted patients, in-hospital transmission and infection related findings. Furthermore, we aimed to capture perspectives of health-care workers and caregivers on effectiveness and burden of infection control measures. Knowledge gained can inform management of the ongoing and future pandemics. We designed a retrospective observational study and survey at a pediatric tertiary care referral center. Local infection control measures and respective guidelines regarding COVID-19 were reviewed. Three thousand seven hundred sixteen children under 18 years were tested for SARS-CoV-2 at the University Children's Hospital Tuebingen and data on SARS-CoV-2 transmission were retrieved from internal records. Two surveys were conducted among 219 staff members and 229 caregivers. Local infection control measures comprised the formation of a task force, triage, protective hygiene measures and an adaptable SARS-CoV-2 test strategy. Between January 2020 and March 2021, SARS-CoV-2 infection was detected in 37 children presenting to our hospital, 21 of these were admitted. One hospital-acquired infection occurred. About 90% of health-care staff perceived the majority of measures as effective and appropriate. However, visitor restrictions and cancellation of scheduled treatments were perceived least effective by hospital staff and as a particular burden for patients and their caregivers. Visits at the pediatric emergency department significantly decreased during the pandemic. We drafted a pandemic action plan by ranking infection control measures according to local transmission stages. SARS-CoV-2 infection control measures implemented in our tertiary care children's hospital were evaluated by health-care workers as mostly effective and appropriate. In particular, good communication, transparency of decision-making as well as universal masking and infection screening were assessed as successful measures of infection control management. Visitor restrictions and cancellation of routine appointments, in contrast, were perceived as a particular burden on patient care and should be avoided. An established pandemic action plan may guide children's hospitals in the future.

Sections du résumé

BACKGROUND
More than 2 years into the COVID-19 pandemic, SARS-CoV-2 still impacts children's health and the management of pediatric hospitals. However, it is unclear which hygiene and infection control measures are effective and useful for pediatric hospitals. Here, we report infection control measures implemented at a tertiary care children's hospital. We evaluated frequency of SARS-CoV-2 detection in admitted patients, in-hospital transmission and infection related findings. Furthermore, we aimed to capture perspectives of health-care workers and caregivers on effectiveness and burden of infection control measures. Knowledge gained can inform management of the ongoing and future pandemics.
METHODS
We designed a retrospective observational study and survey at a pediatric tertiary care referral center. Local infection control measures and respective guidelines regarding COVID-19 were reviewed. Three thousand seven hundred sixteen children under 18 years were tested for SARS-CoV-2 at the University Children's Hospital Tuebingen and data on SARS-CoV-2 transmission were retrieved from internal records. Two surveys were conducted among 219 staff members and 229 caregivers.
RESULTS
Local infection control measures comprised the formation of a task force, triage, protective hygiene measures and an adaptable SARS-CoV-2 test strategy. Between January 2020 and March 2021, SARS-CoV-2 infection was detected in 37 children presenting to our hospital, 21 of these were admitted. One hospital-acquired infection occurred. About 90% of health-care staff perceived the majority of measures as effective and appropriate. However, visitor restrictions and cancellation of scheduled treatments were perceived least effective by hospital staff and as a particular burden for patients and their caregivers. Visits at the pediatric emergency department significantly decreased during the pandemic. We drafted a pandemic action plan by ranking infection control measures according to local transmission stages.
CONCLUSIONS
SARS-CoV-2 infection control measures implemented in our tertiary care children's hospital were evaluated by health-care workers as mostly effective and appropriate. In particular, good communication, transparency of decision-making as well as universal masking and infection screening were assessed as successful measures of infection control management. Visitor restrictions and cancellation of routine appointments, in contrast, were perceived as a particular burden on patient care and should be avoided. An established pandemic action plan may guide children's hospitals in the future.

Identifiants

pubmed: 35473504
doi: 10.1186/s12887-022-03299-x
pii: 10.1186/s12887-022-03299-x
pmc: PMC9039594
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

229

Informations de copyright

© 2022. The Author(s).

Références

JAMA. 2020 May 26;323(20):2087-2089
pubmed: 32301962
J Infect Public Health. 2020 Dec;13(12):1862-1867
pubmed: 33144023
Fam Med Community Health. 2021 May;9(2):
pubmed: 34039654
Influenza Other Respir Viruses. 2020 Jul;14(4):365-373
pubmed: 32246890
J Pediatr. 2020 Jul;222:231-235
pubmed: 32444223
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
Clin Pediatr (Phila). 2013 Apr;52(4):322-8
pubmed: 23406719
Paediatr Respir Rev. 2020 Sep;35:15-19
pubmed: 32600820
Am J Public Health. 2004 Apr;94(4):562-4
pubmed: 15054005
Rev Esp Quimioter. 2020 Dec;33(6):466-484
pubmed: 33070578
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
BMC Infect Dis. 2021 Feb 1;21(1):133
pubmed: 33522901
Lancet Infect Dis. 2020 Oct;20(10):e261-e267
pubmed: 32711692
JAMA. 2020 Aug 18;324(7):703-704
pubmed: 32663246
Clin Infect Dis. 2021 Jul 1;73(1):e141-e143
pubmed: 32562538
Occup Med (Lond). 2020 Mar 12;70(1):3-5
pubmed: 32107548
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
JAMA Netw Open. 2021 Jan 4;4(1):e2035057
pubmed: 33410879
Pediatr Emerg Care. 2021 Jan 1;37(1):48-53
pubmed: 33394945
Am J Infect Control. 2020 Oct;48(10):1225-1230
pubmed: 32771498
Eur J Pediatr. 2021 Apr;180(4):1299-1305
pubmed: 33051714
Infect Control Hosp Epidemiol. 2021 Mar;42(3):261-267
pubmed: 32782038
JAMA Netw Open. 2020 Sep 1;3(9):e2020498
pubmed: 32902653
Front Public Health. 2021 Apr 26;9:630168
pubmed: 33981662
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1466-1467
pubmed: 32576336
J Pediatr. 2021 Mar;230:23-31.e10
pubmed: 33197493
Ann Emerg Med. 2020 Dec;76(6):788-800
pubmed: 32419713

Auteurs

Jonathan Remppis (J)

Department of Hematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.

Johannes Hilberath (J)

Department of Hematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany. johannes.hilberath@med.uni-tuebingen.de.

Tina Ganzenmüller (T)

Institute for Medical Virology and Epidemiology, University Hospital Tuebingen, Tuebingen, Germany.
German Center for Infection Research (DZIF), Tuebingen, Germany.

Christoph Slavetinsky (C)

Department of Hematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.
Interfaculty Institute of Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany.
Pediatric Surgery and Urology, University Children´s Hospital Tuebingen, University of Tuebingen, Tuebingen, Germany.

Malte Kohns Vasconcelos (MK)

Institute for Medical Microbiology and Hospital Hygiene, Heinrich Heine University Duesseldorf, Duesseldorf, Germany.

Marion Gnädig (M)

Department of Hematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.

Jan Liese (J)

Institute of Medical Microbiology and Hygiene, University Hospital Tuebingen, Tuebingen, Germany.

Siri Göpel (S)

Infectious Diseases, Department of Internal Medicine I, University Hospital Tuebingen, Tuebingen, Germany.

Peter Lang (P)

Department of Hematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.

Oliver Heinzel (O)

Department of Hematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.

Hanna Renk (H)

Department of Hematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.
Institute of Medical Microbiology and Hygiene, University Hospital Tuebingen, Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH